
XCEED TL™ is a Tri-layer placental-derived allograft matrix developed using advanced processing techniques, which aims to maintain structural integrity while addressing immunogenic components.
The allograft is designed to retain extracellular matrix proteins and may serve as a natural, biologic barrier or wound cover.
Through minimal manipulation and terminal sterilization, the dehydrated allograft is processed in compliance with FDA and AATB standards.

Amniotic tissue is a type of regenerative material derived from the placenta. It contains growth factors and other bioactive components that promote healing and tissue regeneration.
Amniotic tissue grafts are used in wound care to promote healing and tissue regeneration. They can be applied topically or used in surgical procedures to enhance the body's natural healing process.
Yes, amniotic tissue grafts are considered safe. The tissue is thoroughly screened and processed to ensure it meets the highest quality and safety standards.
Yes, amniotic tissue grafts have been shown to be effective in promoting wound healing and tissue regeneration. They provide a rich source of growth factors and bioactive components that support the body's natural healing process.
To learn more about how to access amniotic tissue grafts for wound care, please contact our team. We will be happy to provide you with the information and assistance you need.